Belotecan
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Belotecan, covering 2014-12-02 to 2018-12-27. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer [Phase 2]